Bevin Lyle Ellenberg, CRNP

Bevin Ellenberg practices at Clearview Cancer Institute in Jasper, Alabama.

Bevin Ellenberg's NPI, 1780100776, was assigned on August 21, 2017. Bevin Ellenberg holds Alabama license 1-140234.

Bevin Ellenberg's primary practice is Clearview Cancer Institute, at 3503 Hwy 78 E, Jasper, AL 35501. The practice phone is (256) 705-4224.

Bevin Ellenberg's primary practice is Clearview Cancer Institute in Jasper, Alabama. Bevin Ellenberg is also affiliated with Baptist Health Walker Hospital. The medical group on file is Clearview Cancer Institute.

Dmand AI tracks the electronic health record (EHR) system at each site where Bevin Ellenberg practices, 2 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Bevin Ellenberg's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Bevin Ellenberg is licensed in Alabama.

CMS counts 265 Medicare patients who saw Bevin Ellenberg in 2024. The largest group is 75 to 84, with 107 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Bevin Ellenberg's median patient age at 69, with 73% women.

In 2024, Bevin Ellenberg wrote 588 Medicare Part D claims for 212 patients. 89% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Bevin Ellenberg for performance year 2024, reported as part of a group. Bevin Ellenberg accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Bevin Ellenberg as offering telehealth.

CMS Open Payments shows 22 general payments to Bevin Ellenberg from 16 drug and device companies in 2025. Consulting fees make up the largest share, 68% of the total. Takeda Pharmaceuticals U.S.A., Inc. paid the most, $1,128.